In a cohort of inpatient hematopoietic cell transplantation (HCT) recipients, we assessed patterns of referral to rehabilitation treatment, functional performance and short-term outcomes in patients who received post-transplant rehabilitation in comparison with those who did not. Among 201 first-time HCT recipients, 53 (26%) were referred to an inpatient rehabilitation provider, had an assessment of functional performance using the Functional Independence Measure scale and underwent rehabilitation treatments to address functional needs. Patients who received rehabilitation therapy were more likely to be females (P = 0.02), older than 60 years of age (P = 0.0146), employed (P = 0.01), have hypertension (P = 0.02), peripheral vascular disease (P = 0.01) and pre-transplant Karnofsky Performance Score (KPS) o 90 (P = 0.02). Mean functional performance scores for transfers and ambulation increased significantly in the group with rehabilitation interventions (P = 0.0022 and P o 0.0001, respectively). There was no difference between the groups that did and did not receive rehabilitation treatments in 30-day re-admission rates. Patients who are 60 years of age or older, with pre-transplant KPS o 90, and pre-transplant hypertension were more likely to be referred for rehabilitation treatments in the early period after HCT. Future studies should be designed to determine the optimal timing and cost effectiveness of functional assessment and rehabilitation treatments in this high-risk population.
INTRODUCTION
In the last two decades, important trends have been seen in the hematopoietic cell transplantation (HCT) field including an increase in the annual number of HCT with a recipient population of increasing age and complexity of chronic medical conditions. 1 Decline in functional performance is an important consequence following HCT. A majority, 66-80%, of cancer patients experience functional impairments that can decrease their quality of life and independence. [2] [3] [4] Further, decreased functional status adversely affects quality of life and is prognostic for poor overall survival in many solid cancers. [5] [6] [7] [8] [9] [10] Functional outcomes have been well-characterized after HCT. 11 Functional ability typically declines immediately after HCT, but improves by 3 months and is back to baseline by 1 year. 11 There is evidence that at 6 weeks post HCT, allogeneic recipients have significantly decreased upper extremity and trunk muscle mass, as well as handgrip strength. 12 Allogeneic HCT is associated with a longer time to functional recovery than autologous transplants. 13 Pre-HCT performance status is predictive of transplant-related mortality and overall 6 month survival after allogeneic HCT. 14, 15 Finally, a number of studies have shown that a structured exercise and physical therapy program during the acute care stay after HCT can improve functional recovery and lower the level of fatigue immediately after HCT. [16] [17] [18] [19] [20] There is a paucity of literature regarding how rehabilitation treatments impact short-term outcomes such as length of hospital stay, 30-day re-admission rate and overall improvement in functional performance. Finally, there are no standardized processes for identifying patients with functional impairments in this early post-transplant period or pathways of their referral for rehabilitation treatments. The objective of our study was to assess patterns of referral to rehabilitation treatment, functional performance and short-term outcomes in patients who received post-transplant rehabilitation in comparison with those who did not.
MATERIALS AND METHODS
This was an International Review Board-approved study conducted at a tertiary medical center. We identified patients who were 18 years of age and older with a malignant or nonmalignant hematologic condition who underwent a first HCT between July 2010 and August 2012 (n = 260). If patients underwent tandem transplantation, the hospital admission after the second procedure was counted for purposes of this study. Patients were excluded if they received the HCT as an outpatient procedure without an acute care hospital stay (n = 59), since those who are transplanted as an outpatient receive rehabilitation therapy services outside the medical center and thus are not documented consistently. Data for the final study cohort consisting of 201 patients was abstracted from the electronic medical records and contained information on demographics, disease, patient and transplant characteristics. Corticosteroid use was measured based on the cumulative number of days a patient received steroids during the post-transplant hospitalization. The specific post-HCT complications collected included infection and/or sepsis, respiratory failure, venous thromboembolism, anemia, thrombocytopenia, engraftment syndrome and death.
Information on rehabilitation treatments includes documented consultation with physical medicine and rehabilitation specialist and/or rehabilitation treatment sessions with a physical therapist, occupational therapist or speech therapist. Patients were referred for rehabilitation treatments based on the fact that they required assistance for mobility and activities of daily living during the post-transplant hospital stay. Standard recommended rehabilitation schedule for patients include three to five 30-min sessions per week.
For patients who had a rehabilitation treatment, additional information was abstracted regarding the patient's functional status based on the documented Functional Independence Measure (FIM) score, during their initial therapy session following transplant and last therapy session prior to discharge. The FIM scale is a seven-point functional assessment tool that measures patient's level of disability in performing a variety of basic functional tasks-mobility, transfers, activities of daily living (grooming, dressing, toileting and so on) and cognition/communication. 21 FIM scores range from 7 (completely independent) to 1 (completely dependent) for each of 18 total functional tasks. Although the FIM score includes 18 total items, we included only FIM scores for bed mobility, transfers and ambulation for purposes of this study as these have a determining role in patients' readiness to be discharged to home environment and were consistently documented in the rehabilitation treatment notes. Thus, a total motor FIM score (sum of individual score for bed mobility, transfers and ambulation) could range from 3 to 21. The FIM score is a standardized measure that is widely used in the field of rehabilitation to monitor functional progress in patients undergoing therapy services.
Outcomes of interest included the length of inpatient hospital stay, allcause 30-day re-hospitalization and overall functional improvement based on change in FIM scores for bed mobility, transfers and ambulation during post-transplant hospitalization. Reasons for 30-day hospital re-admission were categorized as infection, acute/presumed GVHD, cardiac, neutropenia, renal and other. The discharge destination was also recorded when available and categorized into discharge to home, temporary housing, sub-acute or acute rehabilitation facility.
Statistical analysis
Demographic characteristics were summarized using descriptive statistics. Proportions of patients who received therapy and who did not were compared by Fisher's exact test. Fisher's exact test was also used to compare 30-day re-admission rates and KPS among various groups of patients. Continuous variables such as median length of hospital stay were compared between groups via Wilcoxon rank-sum test.
Motor FIM score before and after therapy was summarized by using means and s.d. Paired t-test was used to compare the pre-and post-therapy measurements. Logistic regression model was used to identify factors significant in predicting receipt of rehabilitation treatment. All P-values are two-sided and a level of significance (alpha) of 0.05 was used throughout. SAS, Version 9.3 statistical software (SAS Institute, Cary, NC, USA) was used for all analyses.
RESULTS
A total of 201 patients were included in this study. Table 1 shows the demographic and baseline characteristics of these patients. The mean age was 54 years (range 22-77 years). The majority of subjects were male (56%), white (83%), not employed at the time of the procedure (65%), married (69%) and living with a spouse or other family members (82%) at the time of transplant. Multiple myeloma was the most common type of hematologic malignancy (N = 80), followed by acute myeloid leukemia (N = 39), and NonHodgkin's lymphoma (N = 37). One hundred and twenty (60%) subjects received autologous HCT and 81 (40%) received allogeneic HCT. Only four subjects had a pre-transplant KPS score of 70. Forty subjects had a KPS score of 80. The remaining subjects had a KPS score of 90 (N = 124, 62%) or 100 (N = 33, 16%).
Rehabilitation treatments Fifty three patients (26%) received at least one therapy intervention with physical, occupational or speech therapy. Only four patients were seen by a physical medicine and rehabilitation physician. Table 1 shows a comparison between subjects who did and did not receive a therapy intervention during acute hospital admission. Females were more likely to receive therapy than males (P = 0.02). There was no difference between groups with respect to race, marital status, or living situation. Patients with a history of hypertension (P = 0.02) and peripheral vascular disease (P = 0.01) were more likely to receive therapy, but there were no differences with respect to other comorbidities. There was no significant difference between groups regarding disease type or transplant type. Subjects who had a KPS score o 90 received therapy more often as compared with those who had a KPS score of 90 or higher (P = 0.02).
The mean number of therapy visits during hospital stay was 8.2 (s.d., 16.4) . Physical therapy was the most common type of visit (mean 5.7 (s.d. 8.3)), followed by occupational therapy (mean 2.0 (s.d., 7.1)) and speech therapy (mean 0.5 (s.d. 1.6)). The mean FIM scores for transfers and ambulation from initial to final therapy visit increased significantly (Figure 1 ). The change in FIM score for transfers was 5.6-6.2 and for ambulation was 5.0-5.8 (P = 0.0022 and P o 0.0001, respectively). Scores for bed mobility, transfers and ambulation were combined to give a total motor FIM score, which also improved significantly from initial to final therapy visit, 16.6-18.4 (P = 0.0014; Table 2 ). The FIM efficiency, or amount of improvement in FIM scores per day, was 0.06 (s.d. 0.14).
Outcomes Select outcomes including hospital and intensive care unit stay, steroid usage, post-transplant complications and all-causes 30-day re-admissions are summarized in Table 3 . There was on observed association between post-transplant complications including thrombocytopenia, anemia, infection/sepsis, venous thromboembolism and respiratory failure and receipt of rehabilitation treatments (P o 0.05). More patients receiving rehabilitation treatment had these complications at some time during their acute hospitalization. In addition, patients who received rehabilitation treatment had longer length of stay as compared with those who did not receive similar services during initial hospitalization (median of 18 vs 23 days, P o0.0001). There was no difference between the two groups with respect to steroid use.
Of the 201 patients, 4 died during the initial admission and 197 were discharged alive. For subjects receiving therapy, 32 (60%) were discharged home, 13 (25%) went to temporary housing, 1 (2%) was transferred to sub-acute rehabilitation facility, 4 (8%) admitted to acute inpatient rehabilitation program and 3 (6%) died. For subjects who did not receive therapy, 100 (68%) were discharged home, 46 (31%) went to temporary housing, 1 (1%) to sub-acute rehabilitation facility and 1 (1%) died. The home discharge rate was not significantly different between groups (P = 0.3999).
Forty-seven (23%) of 201 subjects were re-admitted within 30 days of discharge with no difference in rates between groups that did or did not receive inpatient therapy (Table 3) . Infection (51%) and GVHD (38%) were the most common causes of 30-day re-admission (Table 4 ). There were no differences in 30-day readmission rates between groups with respect to demographics, social situation, select or total number of comorbidities and pretransplant KPS score.
In addition, differences in disease type, comorbidities and early outcomes by KPS score were analyzed ( Table 5 ). The group with lower KPS had a higher rate of infection/sepsis (P = 0.01) and death (P = 0.03), although the number of deaths in the study cohort was very low. Subjects with KPS o 90 had longer median hospital length of stay (23 vs 19 days, P = 0.0129), but no difference in 30-day re-admission rate. Table 6 shows a multivariate analysis of potential characteristics that were predictive of those who received a rehabilitation therapy intervention. Patients who were 460 years old, had KPS o90, were employed, were of female gender and who had pre-transplant hypertension were more likely to receive therapy services.
DISCUSSION
This study describes the patterns of referral for rehabilitation treatment among patients hospitalized immediately after HCT and the effect of rehabilitation on early outcomes. Patients who were 60 years of age or older, had pre-transplant KPS score o 90, or were diagnosed with hypertension were significantly more likely to receive rehabilitation treatment. These differences may reflect the population in need of therapy services-those patients who have a lower premorbid functional status and suffer from pre-HCT comorbidities are more likely to experience further functional decline during their hospital stay. It was observed that patients who had rehabilitation therapy also tended to have post-HCT complications more frequently than those who did not have similar therapy. However, the timing of these complications during the course of the hospital stay is not known and thus leaves some uncertainty as to whether the rehabilitation consult was in reaction to these complications or the consult was initiated prior to the development of complications. Despite the higher rate of complications and longer length of stay, the group that received therapy treatment did not have significantly lower 30-day re-admission rates. This could reflect the fact that the most common reasons for 30-day re-admission were related to complications after HCT (infection and GVHD), and not functional deficiencies (need for more assistance with mobility and activities of daily living). Alternatively, this could reflect the return to function in the therapy group comparable to those who did not require therapy, in part due to rehabilitation treatment; however, functional status by FIM assessment in the non-therapy Abbreviations: HL = Hodgkin's lymphoma; KPS = Karnofsky Performance Status; MDS = myelodysplastic syndrome; MM = multiple myeloma; NHL = nonHodgkin's lymphoma. a Other includes chronic myelogenous leukemia (N = 2), aplastic anemia (N = 1), systemic sclerosis (N = 1) and solid tumors (n = 4). **P-value comparing therapy and no therapy groups.
Rehabilitation after hematopoietic stem cell transplant J Laine et al group is unknown in our cohort. Although occurrence of GVHD was assessed as a complication and reason for re-admission in our study, the time period for which our cohort was followed was likely inadequate to determine the true incidence of GVHD. Notably, the median hospital stay was 17 days. Measures of performance status are widely used to predict a patient's tolerance of HCT and to determine eligibility for transplantation. Commonly, measures such as the KPS or Eastern Cooperative Oncology Group scale are used. These rely on the oncologist's assessment of the patient's ability to care for themselves, for example, or the differentiation of minor signs of disease from severe signs of disease. These measures can be somewhat subjective and nonspecific in nature. On the other hand, the FIM score of patient function is based on an assessment by a rehabilitation specialist (physical medicine and rehabilitation physician or rehabilitation therapist-physical, occupational or speech therapist) and is not widely used outside the field of rehabilitation. It is more objective in nature in that it relies on direct observation and assessment of specific functional tasks with a determination of the needed level of assistance and related rehabilitation. In our study, the therapy group consistently improved their function as measured by FIM scores for transfers and ambulation-two necessary functional tasks for safe return home (0.6 and 0.8 difference, respectively, on the FIM scale). This represents a clinically significant improvement in function and decrease in level of assistance patients require for the given tasks. Notably, most of the FIM scores centered around scores of 5 (supervision required) indicating another person was required for the task to be performed, and 6 (modified independence) indicating the task could be performed with assistive devices but without need for supervision. Based on our results, neither the FIM scores nor the KPS scores were predictive of 30-day readmission. However, it should be noted that only patients referred for rehabilitation treatments were assessed with FIM scores. Therefore, although the KPS was a pre-transplant measure, FIM scores were available only post-transplant in a limited group. In order to assess pre-transplant function more precisely with the FIM score would require a prospective approach with a designated pre-transplant FIM assessment by a rehabilitation specialist, a possible next step for our study group.
The KPS has been shown to have a strong predictive value for overall survival in a number of studies in both allogeneic and Table 2 . autologous HCT. 15, 22, 23 In our study, KPS also proved to be a significant predictor of post-transplant complications, most notably, the rate of infection and length of hospital stay. A trend was also noted with a lower incidence of respiratory failure in patients with higher KPS but due to the low overall incidence rate lacked statistical significance. Our findings confirm the known prognostic value of the KPS in predicting not only long-term outcomes but also some immediate post-transplant outcomes.
Our study has some limitations particularly related to its retrospective nature. In our cohort, 26% of patients received post-HCT rehabilitation and thus had functional analysis with the FIM assessment. Furthermore, the rehabilitation treatment was not standardized and the variability in the number of therapy sessions received by each patient limits our ability to accurately gauge its efficacy in an objective manner. A complete FIM evaluation of all 18 functional items would have provided us with a comprehensive understanding of the patients' functional status. Finally, because we did not study outpatient HCT in this group we are unable to comment on particular rehabilitation needs in the outpatient setting. Regardless, our study provides important observations regarding which patients have higher need of post-HCT rehabilitation treatments as well as an objective measure of benefits from rehabilitative interventions. Future studies should be designed to determine the optimal timing and cost effectiveness of rehabilitation consultation in this high-risk population. Following patient's functional status beyond discharge is a next step for our group.
CONCLUSIONS
Patients with pre-transplant hypertension, age 460 years, female and KPS o 90 are more likely to receive rehabilitation during the initial hospitalization for HCT. Neither pre-transplant KPS nor posttransplant FIM predicted 30-day re-admission in this group. No difference in 30-day re-admission was seen between patients who received therapy versus those who did not. Patients who received rehabilitation treatments showed clinically and statistically significant improvement in transfers and mobility during the rehabilitation process. Our analysis shows that patients may benefit from having detailed functional assessments by a rehabilitation specialist after transplant particularly those with comorbidities in order to intervene at an early stage. Further studies are needed to identify specific indications for rehabilitation as well as the role of the FIM assessment in improving treatment outcomes and patients' quality of life. 
